Real-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of the latest data on the...
Source: prnewswire.com